Cytek Biosciences (CTKB) Intangibles (2020 - 2026)

Cytek Biosciences' Intangibles history runs 7 years deep, the most recent figure standing at $15.7 million for Q1 2026.

• Quarterly Intangibles fell 19.18% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (down 19.18% YoY) and the FY2025 annual result came in at $16.8 million, down 16.43% from the prior year.
• Intangibles was $15.7 million for Q1 2026 at Cytek Biosciences, down from $16.8 million in the prior quarter.
• Across five years, Intangibles topped out at $24.7 million in Q1 2023 and bottomed at $3.9 million in Q2 2022.
• A 5-year average of $16.8 million and a median of $19.4 million in 2025 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles jumped 1142.38% — and 2026, when it declined 19.18%.
• Cytek Biosciences' Intangibles stood at $4.3 million in 2022, then jumped by 432.99% to $23.1 million in 2023, then slipped by 12.81% to $20.1 million in 2024, then slipped by 16.43% to $16.8 million in 2025, then dropped by 6.64% to $15.7 million in 2026.
• Business Quant data shows CTKB's Intangibles at $15.7 million in Q1 2026, $16.8 million in Q4 2025, and $17.7 million in Q3 2025.